Detalles de la búsqueda
1.
Experimental and Computational Studies on Structure and Energetic Properties of Halogen Derivatives of 2-Deoxy-D-Glucose.
Int J Mol Sci
; 22(7)2021 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33918425
2.
d-Glucose- and d-mannose-based antimetabolites. Part 4: Facile synthesis of mono- and di-acetates of 2-deoxy-d-glucose prodrugs as potentially useful antimetabolites.
Carbohydr Res
; 531: 108861, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37356236
3.
Synergistic Anticancer Effect of Glycolysis and Histone Deacetylases Inhibitors in a Glioblastoma Model.
Biomedicines
; 9(12)2021 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34944565
4.
IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma.
J Natl Cancer Inst
; 108(12)2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27576731
5.
Convenient approach to higher carbon sugars. First synthesis of the free C12-sugar: D-erythro-L-manno-D-manno-dodecose.
Carbohydr Res
; 338(5): 407-13, 2003 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-12559742
6.
D-Glucose and D-mannose-based metabolic probes. Part 3: Synthesis of specifically deuterated D-glucose, D-mannose, and 2-deoxy-D-glucose.
Carbohydr Res
; 368: 111-9, 2013 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-23376241
7.
Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cells.
Cancer Biol Ther
; 13(8): 657-70, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22555804
8.
Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms.
PLoS One
; 6(9): e24397, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21935404
9.
D-glucose- and D-mannose-based antimetabolites. Part 2. Facile synthesis of 2-deoxy-2-halo-D-glucoses and -D-mannoses.
Carbohydr Res
; 344(12): 1464-73, 2009 Aug 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-19625015
Resultados
1 -
9
de 9
1
Próxima >
>>